[Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
作者信息
Forti E, Wolf D, Melia M
出版信息
Pathologica. 1985 May-Jun;77(1049):241-9.
PMID:3913892
Abstract
摘要
相似文献
1
2
[Tumor markers in human breast cancer].
Gan To Kagaku Ryoho. 1987 Nov;14(11):2998-3003.
3
[Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
Minerva Chir. 1988 Sep 30;43(18 Suppl):5-7.
4
5
Estrogen receptors and tumor associated antigens in breast cancer.乳腺癌中的雌激素受体与肿瘤相关抗原
Ann Clin Lab Sci. 1979 May-Jun;9(3):258-61.
6
[Serum levels and clinical evaluation of CA 19-9 in various diseases].
Gan No Rinsho. 1985 Mar;31(3):293-8.
7
[Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].[4种血清标志物联合检测在各类恶性肿瘤中的优势与局限性]
Minerva Med. 1986 Sep 15;77(34-35):1521-5.
8
[Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].一种新型肿瘤标志物CA 15 - 3在乳腺癌中的临床评估；与癌胚抗原的对比研究
Gan To Kagaku Ryoho. 1986 Oct;13(11):3145-9.
9
[Study on the clinical usefulness of NCC-ST-439 in breast cancer].
Gan To Kagaku Ryoho. 1991 Feb;18(2):245-9.
10
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.血清和组织中的癌胚抗原、铁蛋白及组织多肽抗原。与乳腺癌中受体含量的关系。
Cancer. 1986 Mar 1;57(5):917-22. doi: 10.1002/1097-0142(19860301)57:5<917::aid-cncr2820570506>3.0.co;2-m.
Zotero 插件